NOD2 and obesity due to melanocortin 4 receptor deficiency: Increased expression of NOD2 has been reported in a range of human metabolic diseases, including obesity, diabetes, nonalcoholic fatty liver disease, and metabolic syndrome (Cavallari et al., 2020).